Evidence map›Paper›PMID 31862970›Full record

ArticleScientific reports2019

Application of a multiplex salivary immunoassay to detect sporadic incident norovirus infections.

Timothy J Wade, Shannon M Griffin, Andrey I Egorov, Elizabeth Sams, Edward Hudgens, Swinburne Augustine, Stephanie DeFlorio-Barker, Trevor Plunkett, Alfred P Dufour, Jennifer N Styles and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Breadth and Dynamics of Human Norovirus-Specific Antibodies in the First Year of Life.Journal of the Pediatric Infectious Diseases Society · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Timothy J WadeUnited States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, North Carolina, USA. wade.tim@epa.gov.ORCID http://orcid.org/0000-0002-7843-0997
Shannon M GriffinUnited States Environmental Protection Agency, Office of Research and Development, Cincinnati, Ohio, USA.
Andrey I EgorovUnited States Environmental Protection Agency, Office of Research and Development, Cincinnati, Ohio, USA.
Elizabeth SamsUnited States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, North Carolina, USA.
Edward HudgensUnited States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, North Carolina, USA.
Swinburne AugustineUnited States Environmental Protection Agency, Office of Research and Development, Cincinnati, Ohio, USA.
Stephanie DeFlorio-BarkerUnited States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, North Carolina, USA.
Trevor PlunkettOak Ridge Associated Universities, Oak Ridge, Tennessee, USA.
Alfred P DufourUnited States Environmental Protection Agency, Office of Research and Development, Cincinnati, Ohio, USA.
Jennifer N StylesUnited States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, North Carolina, USA.
Kevin OshimaUnited States Environmental Protection Agency, Office of Research and Development, Cincinnati, Ohio, USA.
Environmental Protection Agency · USOak Ridge Associated Universities · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Norovirus is one of the most common causes of gastroenteritis. Following infection, anti-norovirus salivary immunoglobulin G (IgG) rises steeply within 2 weeks and remains elevated for several months; this immunoconversion can serve as an indicator of infection. We used a multiplex salivary immunoassay to study norovirus infections among 483 visitors to a Lake Michigan beach in 2015. Saliva was collected on the day of the beach visit (S1); after 10-14 days (S2); and after 30-40 days (S3). Luminex microspheres were coupled to recombinant antigens of genogroup I (GI) and II (GII) noroviruses and incubated with saliva. Immunoconversion was defined as at least 4-fold increase in anti-norovirus IgG antibody response from S1 to S2 and a 3-fold increase from S1 to S3. Ten (2.1%) immunoconverted to either GI (2) or GII (8) norovirus. Among those who immunoconverted, 40% reported at least one gastrointestinal symptom and 33% reported diarrhea, compared to 15% (p = 0.06) and 8% (p = 0.04) among those who did not immunoconvert, respectively. The two participants who immunoconverted to GI norovirus both swallowed water during swimming (p = 0.08). This study demonstrated the utility of a non-invasive salivary immunoassay to detect norovirus infections and an efficient approach to study infectious agents in large cohorts.

Indexed as

AdolescentAdultCaliciviridae InfectionsChildChild, PreschoolFemaleHumansImmunoassayInfantInfant, NewbornMaleNorovirusProspective StudiesYoung Adult

Identifiers

PMID31862970
PMCPMC6925267
OpenAlexW2996176074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.